卡路美 CLMT 深 滬
等待開盤 06-10 09:30:00 美东时间
34.05
-1.450
-4.08%
華盛通- 最 高35.44
- 今 開35.13
- 成交量 107.61万股
- 最 低 33.16
- 昨 收 35.50
- 總市值 29.67亿
- 52周最高 38.75
- 市盈率 靜 --
- 換手率 1.23%
- 52周最低 12.935
- 委 比 90.22%
- 總股本 8714.71万
- 歷史最高 38.75
- 量 比 1.14
- 振 幅 6.42%
- 歷史最低 0.82
- 每 手 1
- 風險率 6.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Calumet Specialty Prods Q1 EPS $(3.64) Misses $(0.38) Estimate, Sales $1.029B Beat $957.071M Estimate
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(3.64) per share which missed the analyst consensus estimate of $(0.38) by 857.89 percent. This is a 94.65 percent decrease over losses of $(1.87) per
05-08 19:01
Shares of oil and gas-related companies are trading lower as crude prices pull back amid renewed optimism over potential diplomatic progress between the U.S. and Iran this weekend in Pakistan talks.
Shares of oil and gas-related companies are trading lower as crude prices pull ...
04-25 02:24
卡路美发行1.5亿美元优先票据并参与投资者交流活动
经济观察网 卡路美近期完成了1.5亿美元优先票据的发行，并参与了投资者交流活动。 财务状况 公司于2026年3月完成发行1.5亿美元新增9.75%优先票据，到期...
04-06 01:14
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Calumet Announces Board Member Will Not Stand for Re-Election
INDIANAPOLIS, March 25, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet" or the "Company") announced today that Jennifer Straumins, a member of the Company's Board of Directors (...
03-26 04:05
Shares of oil and gas companies are trading higher as the commodity resumes its rally after Iranian media disputed President Trump's claims that there are U.S.-Iran talks in progress to resolve hostilities in the Middle East. Iran, Israel and the U.S. continued strikes despite alleged talks.
Shares of oil and gas companies are trading higher as the commodity resumes its...
03-24 23:31
新浪财经ESG：卡路美 MSCI（明晟）ESG评级调升至BBB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:15
美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
Goldman Sachs Maintains Buy on Calumet, Raises Price Target to $34
Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price target from $24 to $34.
03-13 01:24
Calumet Subsidiary's TRUFUEL Reports Highest Monthly Sales Volume, Surpassing Previous Peak By 10%
TRUFUEL®, an industry leader in precision-engineered fuel, has achieved the highest monthly sales volume in the company's history, eclipsing the brands' previous monthly high by over 10%.This milestone, which comes
03-04 20:05
